New partnership with Omnicell

With the introduction of innovative, patient-oriented solutions in the healthcare sector, another new partnership has been launched with the global company @Omnicell – a company with many years of experience, which has been developing innovations in the field of drug management and automation for more than 30 years since 1992.

The head of innovation Povilas Norbutas returned from the meeting in Dubai not only with a new partnership agreement, but also with the Omnicell award. The nomination “Strategic Development Partnerships” gives meaning to the new strategic direction of business in the Baltic States with access to the network of partners in the field of health care.

Share:

Related posts

Education on the use of microspheres in radioembolization

The first training programme on the use of radioactive particles in interventional oncology, organised by Terumo Europe, aimed to get to know in more detail the microspheres used in radioembolization procedures in the diagnosis and treatment of liver cancer.

Education on the use of microspheres in radioembolization

The first training programme on the use of radioactive particles in interventional oncology, organised by Terumo Europe, aimed to get to know in more detail the microspheres used in radioembolization procedures in the diagnosis and treatment of liver cancer.

Modern methods of treatment: without large scars and long rehabilitation

Minimally invasive methods of treatment not only cause less pain in patients, but thanks to them, the periods of hospitalization and rehabilitation are shortened, and the risk of complications becomes significantly lower. “Compared to traditional surgery, after which a full recovery occurs only after 6-8 weeks, after minimally invasive procedures, patients can return to the daily routine in a minimum period of 1-2 weeks.